The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis

Mackie ADR, Ferrington C, Cowan S & Palmer KR. (1991)

Alimentary Pharmacology & Therapeutics; 5(2):1-5

View article

Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome

Koletzko, S., Corey, M., Ellis, L., Spino, M., Stringer, D. A., & Durie, P. R. (1990)

The Journal of Pediatrics, 117(5)

View article

Is Gastroparesis Found More Frequently in Patients with Cystic Fibrosis? A Systematic Review

Corral JE, Corey WD, Mascarenhas MR, Barkin JS, Salathe M & Moshiree B (2016)

Scientifica Volume 2016, Article ID 2918139, 11 pages

View article

Late-Age Onset Scleroderma

Manno, R. L. et al. (2011)

Journal of Rheumatology, 38(7), pp. 1317– 1325. doi: 10.3899/jrheum.100956

View article

Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome

Tack, J., Middleton, S. J., Horne, M. C., Piessevaux, H., Bloor, J. S., Meyers, N. L., & Palmer, R. M. J. (2006)

Alimentary Pharmacology and Therapeutics, 23(11), 1655–1665

View article


The information in “published papers” is provided by Atlantic Healthcare plc, and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.